Tranquility Partners’s AstraZeneca AZN Stock Holding History

Tranquility Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$272K	Buy	+1,380	New	+$266K	0.1%	198
2023 Q1	–	Sell	-3,642	Closed	-$494K	–	208
2022 Q4	$494K	Hold	3,642	–	–	0.25%	107
2022 Q3	$399K	Hold	3,642	–	–	0.22%	115
2022 Q2	$481K	Buy	3,642 +924	+34%	+$121K	0.25%	113
2022 Q1	$361K	Hold	2,718	–	–	0.17%	138
2021 Q4	$317K	Sell	2,718 -150	-5%	-$17.6K	0.15%	153
2021 Q3	$344K	Hold	2,868	–	–	0.17%	143
2021 Q2	$344K	Buy	2,868 +93	+3%	+$10.2K	0.19%	133
2021 Q1	$276K	Buy	+2,775	New	+$279K	0.17%	149

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Tranquility Partners's AZN Position: Q1 2026 in Review

Tranquility Partners opened a new position in AstraZeneca (AZN) in Q1 2026: 1,380 shares worth $272K. The stake represents 0.1% of the portfolio and ranks #198 among its holdings. This is a return to the name: Tranquility Partners previously reported a position in AZN as recently as Q4 2022.

Tranquility Partners first reported a position in AZN in Q1 2021 and has held it in 9 quarters since. The position peaked at $494K in Q4 2022. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Tranquility Partners held 1,380 shares of AstraZeneca worth $272K as of Q1 2026.
AstraZeneca was a new Tranquility Partners position in Q1 2026.
AstraZeneca made up 0.1% of Tranquility Partners's portfolio in Q1 2026, its #198 holding.
Tranquility Partners first reported a position in AstraZeneca in Q1 2021 and has held it in 9 quarters since.
Tranquility Partners's AstraZeneca position peaked at $494K in Q4 2022.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Tranquility Partners's 13F filing for Q1 2026, filed 20 Apr 2026.